Abstract 26
In most industrialized countries, screening programs for cervical cancer have 27 shifted from cytology (Pap smear or ThinPrep) alone on clinician-obtained samples to 28 the addition of screening for human papillomavirus (HPV), its main causative agent. For 29 HPV testing, self-sampling instead of clinician-sampling has proven to be equally 30 accurate, in particular for assays that use nucleic acid amplification techniques. In 31 addition, HPV testing of self-collected samples in combination with a follow-up Pap 32 smear in case of a positive result is more effective in detecting precancerous lesions 33 than a Pap smear alone. Self-sampling for HPV testing has already been adopted by 34 some countries, while others have started trials to evaluate its incorporation into 35 national cervical cancer screening programs. Self-sampling may result in more 36 individuals willing to participate in cervical cancer screening, because it removes many 37 of the barriers that prevent women, especially those in low socioeconomic and minority 38 populations, from participating in regular screening programs. Several studies have 39
shown that the majority of women who have been underscreened but who tested HPV-40 positive in a self-obtained sample, will visit a clinic for follow-up diagnosis and 41 management. Additionally, a self-collected sample can also be used for vaginal 42 microbiome analysis, which can provide additional information about HPV infection 43 persistence as well as vaginal health in general. 44
46
Introductionand older, where women are invited to visit their physician for a pelvic exam at regular 77 intervals (Gakidou et al. 2008) . Most of these tests involve a Pap smear (also called a 78 Pap test), in which a physician obtains a cervical specimen for histological or cytological 79 staining and analysis (Tambouret 2013) . The test collects cells from the transformation 80 zone of the cervix, using a small spatula and a brush, analyzing them under the 81 microscope in search of abnormal morphology (Tambouret 2013) . To classify lesions 82 there are several nomenclature systems. Two of the most widespread are the cervical 83 intraepithelial neoplasia (CIN) scale and the Bethesda system (Nayar and Wilbur 2017; 84 Schiffman and Wentzensen 2013; Schiffman et al. 2016 ). The first distinguishes 85 histological lesions by the fraction of epithelium replaced by undifferentiated cells into 86 mild dysplasia (CIN 1), moderate dysplasia (CIN 2), and severe dysplasia and 87 carcinoma in situ (CIN 3) (Nayar and Wilbur 2017; Schiffman and Wentzensen 2013; 88 Schiffman et al. 2016) . The Bethesda system is a cytological classification that 89 describes abnormal findings as negative for intraepithelial lesion and malignancy 90 (NILM), atypical squamous cells of undetermined significance (ASC-US), low-grade 91 squamous intraepithelial lesions (LSILs) or high-grade squamous intraepithelial lesions 92 (HSILs) (Nayar and Wilbur 2017; Schiffman and Wentzensen 2013; Schiffman et al. 93 2016) . 94
Because these classification systems are based on human evaluation via 95 microscopic analysis, and because virtually all cervical cancers are caused by hrHPV 96 (Bosch and Muñoz 2002; Walboomers et al. 1999) , it has been proposed that molecular 97 assays detecting DNA or RNA hrHPV markers might provide a better assessment of 98 cancer risk than cytology (Schiffman et al. 2016; Schiffman 2017) . Several hrHPV 99 assays have been marketed, including Qiagen's hybrid capture signal-based Digene 100
HC2 HPV assay, and several PCR amplification-based tests such as the Cobas test by 101
Roche and the Xpert HPV test from Cepheid. Testing for the presence of hrHPV has 102 proven to be more sensitive for cervical cancer precursors than the Pap test (Mayrand 103 et al. 2007) . In a large Kaiser Permanente study involving over 1 million women, three-104 year risks for CIN3 or worse (CIN3+) or cancer following an HPV-negative result were 105 lower than those following a Pap-negative result, suggesting that testing for HPV is 106 more predictive for the reduced three-year risk of developing cervical cancer and thus a 107 better strategy for cervical cancer screening than a Pap smear (Gage et al. 2014) . 108
These results support the use of hrHPV DNA testing for primary cervical 109 screening, leading to recommendations from the United States, Australia, and Europe to 110 implement HPV screening in nationwide programs (Bessell et al. 2014 , Huh et al. 2015 111 Rijkaart et al. 2012 States for women aged 21-64, not all women respond to these invitations. About 20% of 127 women in the US eligible for cervical cancer screening have not been tested within the 128 recommended timeframe (National Center for Health Statistics, 2017; Watson et al. 129 to invitations and reminders for cervical cancer screening have been found among 137 certain population groups in other countries as well (Chorley et al. 2017) . These 138 disparities are likely to contribute to the higher invasive cervical cancer incidence and 139 mortality rates found among certain ethnic groups (Benard et al. 2014; Musselwhite et 140 al. 2016) . 141
Multiple types of barriers preventing the participation in cervical cancer screening 142 programs have been identified. First, subjective patient experience can decrease 143 participation rates in conventional physician-performed cervical cancer screening 144 (Marlow et al. 2015) . Feelings of embarrassment and shame are often mentioned as 145 reasons to not participate in cervical cancer screening (Chorley et al. 2017; Dzuba et al. 146 2002; Marlow et al. 2015; Waller et al. 2009 ). Women, in particular those of certain 147 sociocultural groups, often report reluctance to having a physician see and touch their 148 genital area (Marlow et al. 2015) . Women who have been sexually abused or who have 149 experienced intimate partner violence are often uncomfortable with a standard pelvic 150 exam (Alcalá et al. 2017; Cadman et al, 2012) . In addition, the experience of discomfort 151 or pain at a past clinical visit can discourage women from visiting a health professional 152 again (Chorley et al. 2017; Jia et al. 2013; Waller et al. 2009). 153 Secondly, lack of understanding about the importance of HPV or cervical cancer 154 screening or underestimation of the risk of disease can also interfere with patient 155 compliance. A study among 12,058 Norwegian women aged 25-45 showed that 156 screening rates were highest among women who were aware of the recommended 157 screening interval for cervical cancer (Hansen et al. 2011 ) and similar results were 158 found in China (Jia et al. 2013 ) and the UK (Marlow et al. 2015) . Additionally, a meta-159 analysis showed that cancer awareness education -either via printed material or face-160 to-face home visits -can increase the participation of women in screening programs 161 (Everett et al. 2011) . 162 Thirdly, practical challenges or socioeconomic barriers may also hinder patient 163 compliance with recommended screening guidelines. In a 2014 study in the Netherlands 164 among 10,000 women who answered a questionnaire about why they had not 165 participated in past cervical screenings, most women answered that they had forgotten 166 to schedule an appointment; other practical reasons were that they were pregnant, 167 breastfeeding, or undergoing fertility treatment (Bosgraaf et al. 2014) . Underestimation 168 of the time elapsed since the previous screening has been identified as another factor 169 associated with non-attendance (Eaker et al. 2001) . In a study among First Nations 170 women in Canada, women living in small rural communities indicated that the time it 171 would take them to drive to clinic for a Pap smear provided a significant barrier to 172 accessing care, because of the disruption to their daily lives and the resulting difficulties 173 with transportation or child care services (Zehbe et al. 2017) . In countries without 174 nationwide health insurance (such as the United States), access to free or low-cost 175 cervical cancer screening is not always readily available for the uninsured. In a National 176
Health Interview Survey in 2013, it was found that only 60.6% of uninsured women in 177 the US were compliant with their recommended Pap smear versus 85.2% of insured 178 women (Sabatino et al. 2015; Smith et al. 2015) . Even in countries with universal 179 healthcare such as Canada and the UK, low socioeconomic status was associated with 180 a lower compliance with cervical cancer screening. In a Canadian study, women in the 181 lowest income neighborhoods were half as likely to be screened (Elit et al. 2012 Care Information Centre showed that women from the highest quintile of income 184 deprivation had 4.9 percentage points less coverage for cervical screening than women 185 from the lowest quintile (Douglas et al. 2016) . 186
The socioeconomic and sociocultural barriers described above prevent many 187 women from complying with recommendations for cervical cancer screening. Not 188 surprisingly, cervical cancer rates are higher in women who have not been screened 189 according to the recommended guidelines (Lam et al. 2017) , with cervical cancer 190 mortality rates being the highest in underscreened populations (Benard et al. 2014; 191 Musselwhite et al. 2016 sampling over clinician sampling (Nelson et al. 2017) . 201
Studies from a range of countries, both on the national level and on specific 202 socioeconomic groups, have shown that offering self-sampling can lead to increased 203 participation rates in cervical cancer screening (Table 1 ). In a study among 30,000 204 women in the Netherlands who had not responded to invitations and reminders for an 205 in-clinic visit and Pap test, one third of the women did return a self-sampling device 206 when provided with the option (Gök et al. 2010; Bosgraaf et al. 2014) . In a study of over 207 3,000 Norwegian women, offering self-sampling materials instead of an invitation for a 208 physician-sampling visit increased compliance to 33.4% from 23.2% (Enerly et al. 209 2016) . Similarly, in a study performed amongst 4,060 Swedish women who had not 210 been screened in at least 6 years, 39% accepted an invitation for self-sampling and 211 HPV testing, while only 9% accepted an invitation for a Pap smear (Wikström et al. 212 2011) . Another study among 8,800 Swedish women who had missed two previous 213 screening rounds found the response rate was significantly higher when self-testing was 214 offered (24.5%) compared to a standard screening invitation (10.6%) (Broberg et al. 215 2014) . A large study among over 14,000 Italian women showed that 11.9% responded 216 to an invitation to undergo an in-clinic Pap smear and 12.0% sent in a sample after 217 having to pick up a kit at a pharmacy, compared with 21.6% who sent in a sample after 218 receiving a self-sampling kit in the mail (Giorgi Rossi et al. 2015) . A randomized 219 controlled trial among 3,000 non-responder women in London showed that sending 220 HPV self-sampling kits to persistent non-responders resulted in a 2.27-fold increased 221 participation rate in cervical cancer screening in comparison with sending an invitation 222 to attend for cervical cytology (Szarewski et al. 2011) . Participation rates among a group 223 of 8,000 under-screened Australian women were much higher when self-sampling was 224 offered (20.3%) than when a Pap-smear reminder was sent (6.0%) (Sultana et al. 225 2016 ). An even more marked difference was obtained in a study of 7,650 women in 226
Argentina, where 86% of women who were offered to self-collect responded for an HPV 227 test, while only 20% of women who were invited to attend a health clinic responded, 228 representing a four-fold increase in patient compliance (Arrossi et al. 2015) . 229
A systematic review regarding different interventions to increase patient 230 screening for various types of cancer combined 7 European studies on cervical cancer 231 screening (several of which are mentioned above) and showed that mailing a self-232 sampling device for HPV testing directly to the patient resulted in an average 2.37-fold 233 higher population participation in non-responder women when compared with a 234 reminder for in-clinic Pap testing (Camilloni et al. 2013) . In a meta-analysis of 10 235 studies, 8 from Europe and 2 from North America, the average compliance of HPV self-236 collected testing was 2.14 times higher compared to an invitation for a Pap smear. It 237 was concluded that HPV self-sampling significantly improves the participation of women 238 in cervical cancer screening (Racey et al. 2013) . A more recent meta-analysis of 16 239 studies found similar results, with about 2.3 times more participants responding to a 240 self-sampling kit sent to their homes, compared to an invitation for a clinician-obtained 241 specimen (Verdoodt et al. 2015) . 242
Self-collection might be of particular benefit for women of certain socioeconomic 243 groups. In a study of 20,000 women from low-income communities in France, where low 244 compliance with recommended Pap smear screening leads to 3,000 new cases of 245 cervical cancer and 1,000 deaths each year, only 2% of women underwent Pap testing, 246 while 18.3% of women responded to an invitation for a self-collected specimen for HPV 247 testing (Sancho-Garnier et al. 2013) . A study involving 346 women from underserved 248 rural areas of Northern Greece, of whom only 17.1% had been regularly participating in 249
Pap smear screening, found that 100% were willing to self-sample, with 90% willing to 250 self-sample regularly if this option was available (Chatzistamatiou et al. 2017) . First 251 Nations women in Canada have a six-fold higher incidence of cervical cancer due to 252 lower participation rates in cervical cancer programs; in a pilot program among 49 First 253 Nations women, self-sampling was well received and the quality of samples was 254 excellent (Zehbe et al. 2011) . A second, larger study involving 834 First Nations women 255 found an 1.3 higher response rate for self-sampling (Zehbe et al. 2016) . In a study led 256 by the University of Michigan, 93% of women from an indigenous community in 257
Guatemala were willing to obtain a self-collected vaginal specimen, 88% provided a 258 sample, and 79% found the test comfortable (Gottschlich et al. 2017) . 259 260 It was estimated that introducing self-sampling could increase participation rates of 271 cervical cancer screening by 6.5% (Wong et al. 2016) . In follow-up interviews with the 272 First Nations study participants described above, many women stated that self-sampling 273 removed key logistical barriers related to making a clinic visit, as well as removed the 274 physical and emotional discomfort of a Pap test (Zehbe et al. 2017) . A group of 746 275
Australian women who self-collected a vaginal sample and returned a questionnaire 276 reported that the home-based test was less embarrassing, less uncomfortable, and 277 more convenient than a clinician-performed Pap test (Sultana et al. 2015) . In a study 278 amongst 1,069 woman in Mexico, women reported that the Pap test caused more 279 discomfort, pain, and embarrassment than self-sampling (Dzuba et al. 2002) . In a series 280 of interviews with low-income indigenous Mexican women who were given self-sampling 281 kits, most women identified the need to be screened for cervical cancer, but identified 282 multiple barriers to making a clinic visit; the self-sampling kits were found less 283 embarrassing and less painful than sampling by a healthcare professional (Allen-Leigh 284 et al. 2017). In a questionnaire of 3049 women in Argentina who were invited to self-285 sample, most women preferred this method because it interfered much less with their 286 daily responsibilities and was less time-consuming than a visit to a clinic (Arrossi et al. 287 2016) . Similar results were found in a study in Santiago, Chile, where 86.5% of 1,254 288 women responded positively to an invitation to self-sample, and 91.6% of these 289 reported self-sampling to be less uncomfortable than Pap testing (Léniz et al. 2013) . 290
German women aged 20 to 30 years, who participated in a study to self-sample by 291 cervicovaginal lavage rated the user-friendliness of the self-sampling method as easy 292 (Deleré et al. 2011) . In a telephone survey of 199 low income women in North Carolina 293 who had not had a Pap test in 4 years, HPV self-tests delivered by mail were perceived 294 to be trustworthy (Galbraith et al. 2014) . However, in a recent study among 1,769 295 women presenting to two University of Washington clinics for routine cervical cancer 296 screening, about 40% of participants were concerned that self-sampling might be 297 inferior to clinician-collected samples, although both patients as well as physicians were 298 supportive of the concept of self-sampling for HPV testing (Mao et al. 2017) . In some 299 studies, women reported that they were afraid to hurt themselves during sampling (e.g., 300
Allen- Leigh et al. 2017; Arrossi et al. 2016; Snijders et al. 2013) . 301
Together, these studies show higher participation rates in self-sampling than 302 physician-performed Pap smear and HPV co-testing. In addition, most women reported 303 positive experiences with HPV self-sampling, which could lead to improved patient 304 compliance. 305 For cytology, using low-grade squamous intraepithelial lesions (LSIL) as the threshold, 322 self sampling was 14% more sensitive to detect CIN2+. For HPV detection, the authors 323 found an overall 12% reduction in sensitivity for the detection of CIN2+ when compared 324 to clinician-collected samples, but this reduced sensitivity was only associated with 325 hybridization signal-based assays, such as used by the Digene HC2 assay. Of note, no 326 reduced sensitivity was found if HPV screening was performed using amplification-327 based methods such as PCR. Overall, these results suggest that self-sampling is an 328 equally good option for women who do not participate in screening programs involving 329 physician-sampling, in particular if self-sampling is combined with DNA amplification, 330
given its improved sensitivity compared against signal-based assays (Arbyn et al. 331 2014) . 332
Other studies published after the meta-analysis by Arbyn and coworkers have 333 confirmed agreement between self-obtained and clinician-obtained samples for the 334 detection of hrHPV types. In a 2016 study using samples from 1,005 women in Papua 335
New Guinea, 93.4% overall agreement was found between self-collected and clinician-336 collected samples using the PCR-based Xpert HPV test to detect hrHPV types (Toliman 337 et al. 2016) . In a study among 194 women from Ghana, the overall HPV detection 338 concordance of the two sampling techniques was 94.2% (Obiri-Yeboah et al. 2017) . A 339 comparison between two self-sampling devices (Evalyn brush versus Qvintip collection 340 device) and clinician sampling on 136 German women showed no significant 341 differences in CIN2+ or CIN+ and specificity of hrHPV testing between self-sampling in 342 comparison with clinician sampling; in addition this same study showed agreement in 343 the overall hrHPV detection rates between self-collected and clinician-collected 344 specimens for both sampling devices, with a kappa of 0.82 for the Evalyn brush and a 345 kappa of 0.78 for the Qvintip device (Jentschke et al. 2016) . Other studies confirmed the high sensitivity of HPV testing from self-collected 359 samples. For example, among a group of 615 women in Costa Rica, HPV testing of 360 self-collected specimens was more sensitive for detecting CIN2+ than cytology. In 361 addition, this study also showed that the proportion of women with initial normal 362 baseline cytology that can develop CIN2+ during the follow up is three times higher than 363 the proportion of women with HPV-negative results (obtained from self-collection) that 364 can develop CIN2+ later (Porras et al. 2015) ; this suggests that HPV-screening may be 365 more informative than cytology for predicting future cancer-related abnormalities. In a 366 study performed amongst 2,000 Swedish women, women were sent an invitation for 367 either self-sampling combined with an HPV test, or a Pap smear by a physician. Women 368 who were HPV-positive after self-sampling were subsequently invited for further 369 examination and histology. The odds ratio of finding histological CIN2 or CIN3 lesions 370 with the self-sampling in comparison to the traditional Pap smear testing was 5.4 371 (Wikström et al. 2011) . Another study among 8,800 Swedish women found similar 372 higher response rates amongst women who were offered self-testing and an odds ratio 373 of CIN2 cytopathology detection of 2.0 (Broberg et al. 2014) . Additionally, the use of 374 self-sampling for HPV screening can also help to capture more HPV-affected individuals 375 in the population. A large study including 28,000 women in the Netherlands found an 376 odds ratio of 2.1 for the detection of CIN2+ lesions in women who had participated in 377 self-sampling screening versus those that did not participate (Gök et al. 2010) . Another 378 study, comprising over 22,000 low income women in Marseille, France, showed that 379 detection of CIN2+ was higher among women offered self-sampling vs. women who 380 received an invitation for a Pap smear (Sancho-Garnier et al. 2013) . In a study of 381 100,000 self-sampled Mexican women, the prevalence of hrHPV was 10.8%, and 382 women with a positive hrHPV test had a relative risk of 15.7 for CIN2+ (Lazcano-Ponce 383 et al. 2013) . Another large study including 13,140 Chinese women showed that HPV 384 self-testing was more sensitive than cytology for the detection of CIN2+ (Zhao et al. 385 2012) . 386
The results of these studies therefore strongly suggest that the use of self- In addition to increasing patient participation and compliance, HPV self-sampling 394 is also useful in motivating under-screened or never-screened patients to engage with 395 their physician for ongoing screening and cervical health care. For example, in a trial 396 reported by Broberg and coworkers (Broberg et al. 2014) , all nine women who tested 397 positive for hrHPV attended an exam for cytology and colposcopy, suggesting that 398 women with hesitations to undergo screening might be motivated to visit a healthcare 399 provider following a positive self-sampling result. Another study conducted in Chile 400
showed that 106 of 124 (85%) women who had not been screened in the previous three 401 years but who were identified as HPV-positive after self-sampling, attended a later 402 colposcopy (Léniz et al. 2013 ). This number was even higher in the Norwegian study 403 where 32 of 34 (94.1%) of the hrHPV-positive women in the self-sampling subgroup 404 attended follow-up (Enerly et al. 2016 ). In the study that included 7,000 under-screened 405
Australian women, 106 of the 140 women (75.7%) who tested positive for hrHPV had 406 colposcopy or cytology within six months (Sultana et al. 2016) , while in the Italian study 407 mentioned above, 142 of the 168 women (84.5%) checked in at a clinic for follow-up 408 examinations (Giorgi Rossi et al. 2015) . The Dutch cohort involving 28,000 women 409 mentioned above identified 757 HPV positive cases through self-sampling, 684 (90.4%) 410 of whom presented for a follow-up with general practitioner (Gök et al. 2010) . In what 411 appeared to be an exception, the study among women in Marseille, France, had a self-412 sampling follow-up rate of only 41% (Sancho-Garnier et al. 2013) . 413
414
More and more countries are accepting self-screening for HPV testing 415
Although self-sampling for the detection of hrHPV types is not currently 416 recommended as part of the standard of care in the United States, it has already been 417 implemented in many countries as a way to increase participation in cervical cancer 418 screening and thus improve outcomes (Madzima et al. 2017) . The Netherlands was the 419 first country to offer women the possibility to self-collect samples for HPV testing instead 420 of going to a clinic for a Pap smear (RIVM 2017; Rozemeijer et al. 2015) . In 2017, the 421 National Cervical Screening Program in Australia switched to a recommended HPV-422 screening every 5 years, with the ability to self-sample under medical/health care 423 supervision (Smith et al. 2016) . The Finnish Cancer Registry has also determined that 424 self-sampling tests for HPV detection are reliable for cancer screening purposes 425 (Karjalainen et al. 2016; Virtanen et al. 2015) . Other countries have started trials with 426 self-sampling to evaluate incorporation of this methodology in official national cervical 427 cancer programs, including the UK (Lim et al. 2017) , Norway (Enerly et al. 2016) , 428
Denmark (Tranberg et al. 2016) , and Switzerland (Viviano et al. 2017 ). In addition, trials 429 have started that incorporate self-sampling amongst particular populations with low 430 screening attendance, such as the Maori in New Zealand (Smith et al. 2017) , Haitian, 431
Hispanic, and African-American women in South Florida (Kobetz et al. 2017 help to increase participation rates (Vorsters et al. 2017) . 438
In the US, a recent randomized controlled trial was started in which 439 underscreened women were offered either patient clinic reminders or the usual care 440 plus home delivered hrHPV self-sampling kits (Winer et al. 2017 ). This trial is the first 441 within the US to evaluate if self-screening could increase cervical cancer participation 442 and be a part of future preventive care. Although the outcomes, such as predictive value 443 to detect precancerous states, have not been reported yet, this trial is timely and an 444 indication that the US might follow in the steps of other countries. 445
446

The role of vaginal microbiome analysis in HPV diagnosis and monitoring 447
The associations between the vaginal microbiota and HPV acquisition, 448 persistence, or progression is a growing area of research and potential treatment 449 intervention. The vaginal microbiota may contribute to delayed HPV clearance, the 450 triggering of carcinogenic pathways, and, thus, cervical cancer risk (Kyrgiou et al. 2017; 451 Mitra et al. 2016) . Self-sampling for HPV with the addition of associated microorganisms 452 may provide patients and providers with increasingly relevant and actionable clinical 453 information. 454
In most women, the healthy vaginal microbiota is characterized by the 455 dominance of one or two members of the Lactobacillus genus, Gram-positive bacteria 456 that are thought to play a key role in the maintenance of a healthy vaginal environment 457 (Smith and Ravel 2017; Younes et al. 2017) . Several microbial community states have 458 been described, with the Lactobacillus-dominated states associated with health, and the 459 more diverse states associated with conditions such as bacterial vaginosis (BV) (Ling et 460 al. 2010; Ravel et al. 2011; Ravel et al. 2013; Srinivasan et al. 2012; Younes et al. 461 2017) . Specific vaginal microbiota signatures can also be seen during an HPV infection; 462 including increased vaginal microbial diversity, decreased Lactobacillus spp. levels, and 463 increased presence of specific microbes such as Sneathia spp. or Gardnerella vaginalis 464 (Gao et al. 2013; Lee et al. 2013; Brotman et al. 2014; Reimers et al. 2016; Shannon et 465 al. 2017) . Certain Lactobacillus spp. may be protective, while other vaginal 466 microorganisms may increase a woman's risk of HPV infection and cervical cancer 467 (Mitra et al. 2016) . In a study of 70 healthy women, the vaginal microbial diversity of 468 HPV-positive women was higher than that of HPV-negative women, and G. vaginalis 469 was found at a higher frequency in HPV-positive women (Gao et al. 2013) . In a 470 longitudinal study of 32 women, each self-collecting twice weekly for 16 weeks, 471 microbiota dominated by certain Lactobacillus spp. were associated with the clearance 472 of HPV levels, while communities with low Lactobacillus spp. and high Atopobium spp. 473 had the slowest clearance rates (Brotman 2014) . In a Korean twin cohort with 68 female 474 twins, HPV-positivity was associated with a lower proportion of Lactobacillus spp., a 475 higher microbial diversity, and higher counts of Sneathia spp. (Lee et al. 2013) . In a 476 study on 60 women from Chicago, certain Lactobacillus spp. abundance was inversely 477 associated with HPV detection (Reimers et al. 2016) . In another study of 65 women, 478 HPV infection was associated with a more diverse microbiome and a lack of certain 479 Lactobacillus spp. (Shannon et al. 2017) . 480
Higher diversity of the vaginal microbiome and lower levels of Lactobacillus 481 (particularly L. jensenii) are also associated with high-grade squamous intraepithelial 482 lesions (HSIL) as compared to low-grade squamous intraepithelial lesions (LSIL) (Mitra 483 et al. 2015) . Additional associations with HSIL include higher levels of species of 484 Sneathia, Anaerococcus and Peptostreptococcus (Mitra et al. 2015) . Patients with 485 cervical cancer have also been shown to have a vaginal microbiota dominated by 486 certain cytokines and Fusobacterium (Audirac-Chalifour et al. 2016) . 487
The vaginal microbiome composition as found in BV is in particular associated 488 with the presence or clearance of HPV. A meta-analysis covering 12 studies showed a 489 positive correlation between BV and HPV infection (Gillet et al. 2011) . Additionally, 490 patients with persistent HPV infection showed a significantly higher prevalence of BV 491 than patients with HPV clearance (Guo et al. 2012) . Another study showed an 492 association between cervical neoplasia (CIN2+) and the presence of BV (odds ratio: 493 3.90), providing additional support for the association between BV, HPV infection, and 494 cervical cancer development (de Castro-Sobrinho et al. 2016) . 495
The vaginal microbiome is an emerging treatment area; HPV self-sampling with 496 vaginal microbial analysis can help provide patients with additional information related 497 to HPV, cervical cancer, and their overall vaginal health (Bik et al. 2017) . In addition to 498 standard guidelines for monitoring and treatment of abnormal results, patients may also 499 benefit from microbiome specific interventions including probiotics, prebiotics, dietary 500 suggestions, hygiene and sexual practices, and contraceptive management (Kyrgiou et 501 al. 2017; Mitra et al. 2016) . 502
503
Discussion and conclusions 504
There is an international consensus that participation in cervical cancer 505 screening programs remains a key factor in improving patient outcomes. However, 506 many individuals do not comply with standard screening guidelines, often for a 507 combination of reasons. For example, poor patient compliance may be caused by lack 508 of time for a clinical visit, embarrassment related to the pelvic exam, and/or previous 509 discomfort or pain during a Pap smear (Allen-Leigh et al. 2017; Dzuba et al. 2002; 510 Sultana et al. 2015) . Sociocultural and socioeconomic barriers may also cause women 511 to postpone or decline regular cervical cancer screening. The percentage of women 512 who have not had a Pap smear according to health care guidelines is higher among 513 certain minority populations such as American Indians and Asians, as well as those who 514 live below poverty level (National Center for Health Statistics, 2017) . The use of self-515 collection for vaginal specimens for hrHPV screening has the potential to improve 516 patient access to care, lead to higher patient compliance than current cervical cancer 517 screening programs, and thus impact cervical cancer detection rates (Camilloni et al. 518 2013; Verdoodt et al. 2015; Wong et al. 2016) . 519
High-risk HPV testing on self-collected specimens with subsequent follow-up visit 520 to a physician and cytology on positive cases has also been shown to be more sensitive 521 when compared to Pap smears taken by a health professional in detecting CIN2+ 522 pathology (see e.g. Snijders et al. 2013 , and other studies mentioned above). In 523 addition, a negative HPV test is more predictive for a reduced three-year risk of 524 developing cervical cancer than a negative Pap smear (Gage et al. 2014) . Therefore, 525 screening for hrHPV through self-sampling with appropriate follow-up for positive results 526 may potentially be more effective than routine Pap smears (Schmeink et al. 2011) . 527
Despite the advantages, self-sampling may also present new challenges for 528 patient care. For example, self-sampling could conceivably decrease the opportunities 529 for direct contact between the patient and the clinician, contributing to the possibility of 530 decreased follow-up, as well as the potential for over-testing. Self-sampling without 531 appropriate follow-up also has the potential to increase patient anxiety in the case of a 532 positive result, especially given the likelihood of many HPV infections to clear 533 spontaneously. In all of these cases, HPV education (see Everett et al. 2011) is 534 important to ensure appropriate patient engagement. Moving forward, additional 535 infrastructure and guidelines will be needed to support the use of HPV self-sampling; 536 new processes are already in development in many countries currently implementing 537 self-sampling as part of their national cervical cancer screening protocol. 538
An emerging area related to HPV screening is the role of vaginal microbiome 539 analysis in detecting the presence of commensal and pathogenic bacteria that are 540 positively or negatively associated with HPV infection. Self-sampling has the potential to 541 encourage women to engage regularly with their physician for appropriate cervical 542 cancer screening, while also providing unique insights into vaginal health. Recent 543 developments in vaginal microbiome testing have now made detection of HPV and 544 associated microorganisms readily accessible, providing additional information with the 545 potential to complement and improve the diagnosis and control of HPV infection and 546 cervical cancer (Bik et al. 2017) . 547
With the USPSTF now proposing a shift in cervical cancer screening for average-548 risk women aged 30-65 to hrHPV testing alone every 5 years (without cervical cytology), 549 self-sampling may become an even more viable option for many women in the US. With 550 appropriate patient education and access to follow-up, HPV self-sampling has the 551 potential to improve participation in screening programs, to reduce socioeconomic 552 barriers to care, to improve the subjective patient experience, and ultimately, to further 553 reduce the continued morbidity and mortality related to HPV infection and cervical 554 11. Bik, E.M., Bird, S.W., Bustamante, J.P., Leon, L.E., Nieto, P.A., Addae, K., 602
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